Garland Capital Management Inc Pfizer Inc Transaction History

Garland Capital Management Inc

$130 Million
Q3 2024

A detailed history of Garland Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Garland Capital Management Inc holds 122,731 shares of PFE stock, worth $3.36 Million. This represents 2.73% of its overall portfolio holdings.

Number of Shares

122,731

Previous 138,222 11.21%

Holding current value

$3.36 Million

Previous $3.87 Million 8.17%

% of portfolio

2.73%

Previous 2.73%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$27.7 - $31.39 $429,100 - $486,262	-15,491 Reduced 11.21%	122,731 $3.55 Million
Q2 2024 Jul 30, 2024	BUY	$25.26 - $29.6 $60,017 - $70,329	2,376 Added 1.75%	138,222 $3.87 Million
Q1 2024 Apr 30, 2024	BUY	$25.89 - $29.73 $216,647 - $248,780	8,368 Added 6.56%	135,846 $3.77 Million
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $200,338 - $260,217	-7,667 Reduced 5.67%	127,478 $3.67 Million
Q3 2023 Oct 31, 2023	BUY	$32.09 - $37.51 $91,649 - $107,128	2,856 Added 2.16%	135,145 $4.48 Million
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $50,748 - $58,714	1,405 Added 1.07%	132,289 $4.85 Million
Q1 2023 Apr 25, 2023	SELL	$39.39 - $51.28 $57,509 - $74,868	-1,460 Reduced 1.1%	130,884 $5.34 Million
Q4 2022 Jan 19, 2023	BUY	$41.75 - $54.5 $179,065 - $233,750	4,289 Added 3.35%	132,344 $0
Q3 2022 Oct 20, 2022	BUY	$43.76 - $53.42 $109,400 - $133,550	2,500 Added 1.99%	128,055 $5.6 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $310,355 - $367,983	-6,670 Reduced 5.04%	125,555 $6.58 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $163,556 - $202,666	-3,575 Reduced 2.63%	132,225 $6.85 Million
Q4 2021 Feb 03, 2022	SELL	$41.32 - $61.25 $407,002 - $603,312	-9,850 Reduced 6.76%	135,800 $8.02 Million
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $47,100 - $60,504	-1,200 Reduced 0.82%	145,650 $6.26 Million
Q1 2021 Apr 21, 2021	BUY	$33.49 - $37.77 $10,047 - $11,331	300 Added 0.2%	146,850 $5.32 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $23,429 - $29,792	700 Added 0.48%	146,550 $5.4 Million
Q3 2020 Apr 21, 2021	SELL	$31.75 - $37.25 $6.38 Million - $7.49 Million	-201,023 Reduced 57.95%	145,850 $5.35 Million
Q3 2020 Oct 22, 2020	BUY	$31.75 - $37.25 $6.36 Million - $7.46 Million	200,273 Added 136.61%	346,873 $12.7 Million
Q2 2020 Jul 24, 2020	SELL	$30.12 - $36.54 $78,312 - $95,004	-2,600 Reduced 1.74%	146,600 $4.79 Million
Q1 2020 Apr 13, 2020	BUY	$27.03 - $38.62 $18,731 - $26,763	693 Added 0.47%	149,200 $4.87 Million
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $4,938 - $5,604	150 Added 0.1%	148,507 $5.82 Million
Q3 2019 Oct 10, 2019	SELL	$32.49 - $42.13 $40,125 - $52,030	-1,235 Reduced 0.83%	148,357 $5.33 Million
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $68,413 - $76,812	-1,850 Reduced 1.22%	149,592 $6.48 Million
Q1 2019 Apr 18, 2019	SELL	$37.5 - $41.2 $29,062 - $31,930	-775 Reduced 0.51%	151,442 $6.43 Million
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $18,465 - $21,052	-480 Reduced 0.31%	152,217 $6.64 Million
Q3 2018 Mar 12, 2019	SELL	$34.47 - $41.81 $41,881 - $50,799	-1,215 Reduced 0.79%	152,697 $6.73 Million
Q2 2018 Jul 13, 2018	SELL	$32.98 - $35.16 $276,108 - $294,359	-8,372 Reduced 5.16%	153,912 $5.58 Million
Q1 2018 Apr 24, 2018	BUY	$31.91 - $37.02 $137,213 - $159,186	4,300 Added 2.72%	162,284 $5.76 Million
Q4 2017 Jan 25, 2018	SELL	$33.26 - $35.29 $23,780 - $25,232	-715 Reduced 0.45%	157,984 $5.72 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $4.92 Million - $5.42 Million	158,699	158,699 $5.67 Million

Others Institutions Holding PFE

# of Institutions

3,245

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Garland Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Garland Capital Management Inc with notifications on news.

Account

Garland Capital Management Inc Pfizer Inc Transaction History